Boning Gao

5PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2024
SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition.

Xinxin Song, Zhuan Zhou, Ammar Elmezayen

|Aug 08, 2022
Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale

|Jul 26, 2022
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale

|Jan 18, 2020
SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-Deoxyguanosine.

Ilgen Mender, Kimberly Batten, Michael Peyton

Pageof 1